Fairchem Organics Ltd
Fairchem Organics Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Fairchem aims to increase exports from 9% to 50% of turnover over the next few years without requiring new CAPEX, utilizing existing spare capacity. Management is cautiously optimistic about outlook given improved trade agreements (US, UK, EU) and tariff structures.
From Fairchem Organics Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Fairchem aims to increase exports from 9% to 50% of turnover over the next few years without requiring new CAPEX, utilizing existing spare capacity.
- The company expects volume and value growth starting from H2 FY’27, driven by improved trade agreements with the US, UK, and EU.
- Export opportunities, especially for isosteric acid and dimer fatty acid, are expected to open up with new trade deals, boosting revenues.
- Raw material price reductions and removal of export incentives by China are anticipated to improve margins and increase production.
2 more points from Fairchem Organics Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Fairchem Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No new CAPEX is planned for the next two years as the company has substantial spare capacity to support growth targets, including reaching 50% export turnover.
- The animal feed plant is ready and awaiting GMP certification to start production; initial capacity is small with plans for expansion post buyer approvals.
- A new product is expected to launch by Q3, with initially small capacity to manage approvals before scaling up.
- Future CAPEX focused on low-cost, scalable additions linked to new products rather than large expansions.
2 more points from Fairchem Organics Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Fairchem Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly mention the current or expected order book or pending orders in specific terms.
- However, it is indicated that the company faced volume and realization challenges primarily due to external factors like lower offtake from the paint segment and export discontinuations.
- The company has spare manufacturing capacity (around 55% utilization), capable of handling increased volumes without additional CAPEX.
- The management is optimistic about volume and value growth resuming from H2 FY’27, driven by improved trade agreements with the US, UK, and EU.
- Orders for products like isosteric acid and dimer fatty acid are expected to increase once trade issues normalize.
2 more points from Fairchem Organics Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Fairchem Organics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹117 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fairchem Organic's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Neochem Bio (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chem. (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- Gujarat Alkalies (Q3 FY26)
3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai
- Jubilant Agri (Q3 FY26)
Q3 FY26 Revenue from Operations: INR 4,510 million, up 13% YoY from INR 3,975 million in Q3 FY25 (Page 20). Key investor presentation takeaways from Jubilant Ag
Arthneeti Pro · Annual
Fairchem Organics Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fairchem Organics Ltd Q3 FY26 results?
Fairchem aims to increase exports from 9% to 50% of turnover over the next few years without requiring new CAPEX, utilizing existing spare capacity. Management is cautiously optimistic about outlook given improved trade agreements (US, UK, EU) and tariff structures.
What is Fairchem Organics Ltd share price analysis?
Fairchem Organics Ltd currently shows a neutral. The stock trades at a P/E of 66.5 with a market cap of ₹1,005 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fairchem Organics Ltd planning capital expenditure?
No new CAPEX is planned for the next two years as the company has substantial spare capacity to support growth targets, including reaching 50% export turnover.
Keep Fairchem Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.